KBC Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $117K | Sell |
1,121
-299
| -21% | -$31.2K | ﹤0.01% | 1101 |
|
|
2025
Q1 | $166K | Buy |
1,420
+84
| +6% | +$9.82K | ﹤0.01% | 1171 |
|
|
2024
Q4 | $113K | Buy |
1,336
+385
| +40% | +$32.6K | ﹤0.01% | 1472 |
|
|
2024
Q3 | $85K | Hold |
951
| – | – | ﹤0.01% | 1389 |
|
|
2024
Q2 | $77K | Hold |
951
| – | – | ﹤0.01% | 1330 |
|
|
2024
Q1 | $76K | Buy |
951
+264
| +38% | +$21.1K | ﹤0.01% | 1276 |
|
|
2023
Q4 | $55K | Sell |
687
-109
| -14% | -$8.73K | ﹤0.01% | 1451 |
|
|
2023
Q3 | $56K | Buy |
+796
| New | +$56K | ﹤0.01% | 1345 |
|